Arrhythmia Cohort Study

Not yet recruiting

• Conditions: Arrhythmia
• Interventions: Device: Normal treatment with catheter ablation or medicine; Drug: Drug Treatment

• Registration Number: NCT07123896
• Lead Sponsor: Beijing Anzhen Hospital

Brief Summary

The goal of this prospective, observational registry study is to evaluate the long-term effectiveness, safety, and impact of different kinds of treatment on the quality of life across diverse arrhythmia subtypes and patient populations in hospitalized adults with cardiac arrhythmias (including atrial fibrillation, atrial flutter, supraventricular tachycardia, and ventricular arrhythmias) undergoing routine clinical care.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2025-07-29
• Status Verified: 2025-08
• Study First Submitted QC: 2025-08-12
• Last Update Submitted: 2025-08-12
• Study First Posted: 2025-08-14
• Last Update Posted: 2025-08-14
• Study Start: 2025-08-24
• Primary Completion: 2030-07-24
• Study Completion: 2030-07-24

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 10000

Inclusion Criteria

• Patients hospitalized for any type of arrhythmia

Exclusion Criteria

• Patients currently participating in interventional clinical trials that may confound data collection or outcome assessment in this study.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Treatment	Normal treatment with catheter ablation or medicine	-
Treatment	Drug Treatment	-

Primary Outcome Measures

Name	Time	Method
Arrhythmia recurrence	1 year	Recurrence of the arrhythmia after treatment
All-cause death	1 year	Death due to any reason

Secondary Outcome Measures

Name	Time	Method
Arrhythmia recurrence	5 year	Recurrence of the arrhythmia after treatment
All-cause death	5 year	Death due to any reason
Cardiovascular death	5 year	Death due to cardiovascular disease
Heart failure	5 year	Heart failure due to cardiovascular disease
Cardiovascular hospitalization	5 year	Hospitalization due to cardiovascular disease

Trial Locations

Locations (1)

Deyong Long; 🇨🇳 Beijing, China